A detailed history of Fmr LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Fmr LLC holds 13,624,036 shares of EXAS stock, worth $951 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,624,036
Previous 1,334,926 920.58%
Holding current value
$951 Million
Previous $92.2 Million 524.39%
% of portfolio
0.04%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $508 Million - $913 Million
12,289,110 Added 920.58%
13,624,036 $576 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $25.4 Million - $33.4 Million
452,200 Added 51.23%
1,334,926 $92.2 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $127 Million - $163 Million
-2,149,302 Reduced 70.89%
882,726 $65.3 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $4.35 Million - $6.53 Million
-65,935 Reduced 2.13%
3,032,028 $207 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $15.5 Million - $23.5 Million
246,908 Added 8.66%
3,097,963 $291 Million
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $125 Million - $187 Million
2,642,288 Added 1265.66%
2,851,055 $193 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $1.43 Million - $2.5 Million
46,992 Added 29.05%
208,767 $10.3 Million
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $2.93 Million - $4.52 Million
91,616 Added 130.58%
161,775 $5.26 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $262,089 - $561,052
-7,360 Reduced 9.49%
70,159 $2.76 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $14.2 Million - $20.3 Million
-246,176 Reduced 76.05%
77,519 $5.42 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $41.9 Million - $58.2 Million
-577,695 Reduced 64.09%
323,695 $25.2 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $2.36 Million - $3.24 Million
-26,155 Reduced 2.82%
901,390 $86 Million
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $86.9 Million - $129 Million
927,545 New
927,545 $115 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.